Nothing Special   »   [go: up one dir, main page]

Van Mourik et al., 1984 - Google Patents

Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.

Van Mourik et al., 1984

View PDF
Document ID
3980987153876705707
Author
Van Mourik J
Lawrence D
Loskutoff D
Publication year
Publication venue
Journal of Biological Chemistry

External Links

Snippet

Cultured bovine aortic endothelial cells are associated with an unusually stable fibrinolytic inhibitor (Loskutoff, DJ, van Mourik, JA, Erickson, LA, and Lawrence, D.(1983) Proc. Natl. Acad. Sci. USA 80, 2956-2960). This inhibitor was purified to apparent homogeneity from …
Continue reading at www.sciencedirect.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors

Similar Documents

Publication Publication Date Title
Van Mourik et al. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.
Levin et al. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.
Mimuro et al. Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor
Andreasen et al. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
Kruithof et al. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma
Hekman et al. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.
Koivunen et al. Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor‐associated trypsinogen
Plow et al. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.
Levin et al. Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.
Levin et al. Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells
Citarella et al. Structure/function analysis of human factor XII using recombinant deletion mutants: evidence for an additional region involved in the binding to negatively charged surfaces
EP0187814B1 (en) Diagnostic assay for inhibitor or tissue-type and urokinase-type plasminogen activators
Loskutoff et al. Interactions between fibrin and the plasminogen activators produced by cultured endothelial cells
AU611095B2 (en) Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor
Booth et al. Plasminogen activator inhibitor from human endothelial cells: purification and partial characterization
Kohno et al. Kidney plasminogen activator: a precursor form of human urokinase with high fibrin affinity
EP0234051A1 (en) Tissue-type plasminogen activator mutants; recombinant genetic information coding therefor and process for preparing said mutants; their use and pharmaceutical compositions
Danø et al. Purification and characterization of a plasminogen activator from mouse cells transformed by an oncogenic virus
Lacave et al. Characterization of a plasminogen activator and its inhibitor in human mesangial cells
Erickson et al. Denaturant-induced stimulation of the β-migrating plasminogen activator inhibitor in endothelial cells and serum
Friedberg et al. The role of endothelium in factor Xa regulation: the effect of plasma proteinase inhibitors and hirudin
Früh et al. Human myeloblastin (leukocyte proteinase 3): reactions with substrates, inactivators and activators in comparison with leukocyte elastase
JPS63500564A (en) monoclonal antibody
FACTOR Hageman factor and its substrates: The role of Factor XI, prekallikrein, and plasminogen proactivator in coagulation, fibrinolysis, and kinin generation
Lee et al. Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies